|
1
|
Yosipovitch G and Papoiu AD: What causes
itch in atopic dermatitis? Curr Allergy Asthma Rep. 8:306–311.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sanders KM, Nattkemper LA and Yosipovitch
G: Advances in understanding itching and scratching: A new era of
targeted treatments. F1000Res. 5:F1000 Faculty Rev-2042. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mollanazar NK, Smith PK and Yosipovitch G:
Mediators of chronic pruritus in atopic dermatitis: Getting the
itch out? Clin Rev Allergy Immunol. 51:263–292. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tani E, Shiosaka S, Sato M, Ishikawa T and
Tohyama M: Histamine acts directly on calcitonin gene-related
peptide- and substance P-containing trigeminal ganglion neurons as
assessed by calcium influx and immunocytochemistry. Neurosci Lett.
115:171–176. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dunford PJ, Williams KN, Desai PJ,
Karlsson L, McQueen D and Thurmond RL: Histamine H4 receptor
antagonists are superior to traditional antihistamines in the
attenuation of experimental pruritus. J Allergy Clin Immunol.
119:176–183. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Simons FE, Simons KJ, Becker AB and Haydey
RP: Pharmacokinetics and antipruritic effects of hydroxyzine in
children with atopic dermatitis. J Pediatr. 104:123–127. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stempelj M and Ferjan I: Signaling pathway
in nerve growth factor induced histamine release from rat mast
cells. Inflamm Res. 54:344–349. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Metcalfe DD, Peavy RD and Gilfillan AM:
Mechanisms of mast cell signaling in anaphylaxis. J Allergy Clin
Immunol. 124:639–646; quiz 647–648. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nemeth K, Wilson T, Rada B, Parmelee A,
Mayer B, Buzas E, Falus A, Key S, Masszi T, Karpati S and Mezey E:
Characterization and function of histamine receptors in human bone
marrow stromal cells. Stem Cells. 30:222–231. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nordlind K, Chin LB, Ahmed AA, Brakenhoff
J, Theodorsson E and Liden S: Immunohistochemical localization of
interleukin-6-like immunoreactivity to peripheral nerve-like
structures in normal and inflamed human skin. Arch Dermatol Res.
288:431–435. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stevens SR, Hanifin JM, Hamilton T, Tofte
SJ and Cooper KD: Long-term effectiveness and safety of recombinant
human interferon gamma therapy for atopic dermatitis despite
unchanged serum IgE levels. Arch Dermatol. 134:799–804. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Q, Putheti P, Zhou Q, Liu Q and Gao
W: Structures and biological functions of IL-31 and IL-31
receptors. Cytokine Growth Factor Rev. 19:347–356. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Takaoka A, Arai I, Sugimoto M, Yamaguchi
A, Tanaka M and Nakaike S: Expression of IL-31 gene transcripts in
NC/Nga mice with atopic dermatitis. Eur J Pharmacol. 516:180–181.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Weidinger S, Beck LA, Bieber T, Kabashima
K and Irvine AD: Atopic dermatitis. Nat Rev Dis Primers. 4:12018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee CH: Progress of pruritus research in
atopic dermatitis. Biomol Ther. 18:246–256. 2010. View Article : Google Scholar
|
|
16
|
Rukwied R, Lischetzki G, McGlone F, Heyer
G and Schmelz M: Mast cell mediators other than histamine induce
pruritus in atopic dermatitis patients: A dermal microdialysis
study. Br J Dermatol. 142:1114–1120. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Başer KHC, Demirci B, Dekebo A and Dagne
E: Essential oils of some Boswellia spp., Myrrh and Opopanax.
Flavour Fragr J. 18:153–156. 2003. View
Article : Google Scholar
|
|
18
|
Ljaljević Grbić M, Unković N, Dimkić I,
Janaćković P, Gavrilović M, Stanojević O, Stupar M, Vujisić L,
Jelikić A, Stanković S and Vukojević J: Frankincense and myrrh
essential oils and burn incense fume against micro-inhabitants of
sacral ambients. Wisdom of the ancients? J Ethnopharmacol.
219:1–14. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mohamed AA, Ali SI, El-Baz FK, Hegazy AK
and Kord MA: Chemical composition of essential oil and in vitro
antioxidant and antimicrobial activities of crude extracts of
Commiphora myrrha resin. Industr Crops Prod. 57:10–16. 2014.
View Article : Google Scholar
|
|
20
|
Albrecht U, Muller V, Schneider B and
Stange R: Efficacy and safety of a herbal medicinal product
containing myrrh, chamomile and coffee charcoal for the treatment
of gastrointestinal disorders: A non-interventional study. BMJ Open
Gastroenterol. 1:e0000152015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Langhorst J, Varnhagen I, Schneider SB,
Albrecht U, Rueffer A, Stange R, Michalsen A and Dobos GJ:
Randomised clinical trial: A herbal preparation of myrrh, chamomile
and coffee charcoal compared with mesalazine in maintaining
remission in ulcerative colitis-a double-blind, double-dummy study.
Aliment Pharmacol Ther. 38:490–500. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shameem I: Phytochemical & therapeutic
potentials of Murr Makki (Commiphora myrrha): A review. Indian J
Appl Res. 8:102–104. 2018.
|
|
23
|
Hanus LO, Rezanka T, Dembitsky VM and
Moussaieff A: Myrrh-Commiphora chemistry. Biomed Papers Med Faculty
Univ Palacky, Olomouc, Czechoslovakia. 149:3–27. 2005. View Article : Google Scholar
|
|
24
|
Baek SJ and Kim DH: The Study on
anti-obesity of Myrrh ethanol extract. Korea J Herbol. 31:11–18.
2016. View Article : Google Scholar
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jamshidi-Kia F, Lorigooini Z and
Amini-Khoei H: Medicinal plants: Past history and future
perspective. J Herbmed Pharmacol. 7:1–7. 2018. View Article : Google Scholar
|
|
27
|
Panche AN, Diwan AD and Chandra SR:
Flavonoids: An overview. J Nutr Sci. 5:e472016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim MS, Bae GS, Park KC, Koo BS, Kim BJ,
Lee HJ, Seo SW, Shin YK, Jung WS, Cho JH, et al: Myrrh inhibits
LPS-induced inflammatory response and protects from cecal ligation
and puncture-induced sepsis. Evid Based Complement Alternat Med.
2012:2787182012.PubMed/NCBI
|
|
29
|
Tipton DA, Lyle B, Babich H and Dabbous
MKh: In vitro cytotoxic and anti-inflammatory effects of myrrh oil
on human gingival fibroblasts and epithelial cells. Toxicol In
Vitro. 17:301–310. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fatani AJ, Alrojayee FS, Parmar MY,
Abuohashish HM, Ahmed MM and Al-Rejaie SS: Myrrh attenuates
oxidative and inflammatory processes in acetic acid-induced
ulcerative colitis. Exp Ther Med. 12:730–738. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kawakami Y, Hartman SE, Holland PM, Cooper
JA and Kawakami T: Multiple signaling pathways for the activation
of JNK in mast cells: Involvement of Bruton's tyrosine kinase,
protein kinase C and JNK kinases, SEK1 and MKK7. J Immunol.
161:1795–1802. 1998.PubMed/NCBI
|
|
32
|
Park HJ, Lee HJ, Choi MS, Son DJ, Song HS,
Song MJ, Lee JM, Han SB, Kim Y and Hong JT: JNK pathway is involved
in the inhibition of inflammatory target gene expression and
NF-kappaB activation by melittin. J Inflamm (Lond). 5:72008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Craig R, Larkin A, Mingo AM, Thuerauf DJ,
Andrews C, McDonough PM and Glembotski CC: p38 MAPK and NF-kappa B
collaborate to induce interleukin-6 gene expression and release.
Evidence for a cytoprotective autocrine signaling pathway in a
cardiac myocyte model system. J Biol Chem. 275:23814–23824. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Che DN, Cho BO, Shin JY, Kang HJ, Kim YS
and Jang SI: Fisetin inhibits IL-31 production in stimulated human
mast cells: Possibilities of fisetin being exploited to treat
histamine-independent pruritus. Life Sci. 201:121–129. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Maier E, Werner D, Duschl A, Bohle B and
Horejs-Hoeck J: Human Th2 but not Th9 cells release IL-31 in a
STAT6/NF-κB-dependent way. J Immunol. 193:645–654. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang Y, Zhou B, Lu J, Chen Q, Ti H, Huang
W, Li J, Yang Z, Jiang Z and Wang X: Inhibition of influenza virus
via a sesquiterpene fraction isolated from Laggera pterodonta by
targeting the NF-κB and p38 pathways. BMC Complement Altern Med.
17:252017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Salminen A, Lehtonen M, Suuronen T,
Kaarniranta K and Huuskonen J: Terpenoids: Natural inhibitors of
NF-kappaB signaling with anti-inflammatory and anticancer
potential. Cell Mol Life Sci. 65:2979–2999. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Deepak V, Kasonga A, Kruger MC and Coetzee
M: Inhibitory effects of eugenol on RANKL-induced osteoclast
formation via attenuation of NF-κB and MAPK pathways. Connect
Tissue Res. 56:195–203. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Karunaweera N, Raju R, Gyengesi E and
Münch G: Plant polyphenols as inhibitors of NF-κB induced cytokine
production-a potential anti-inflammatory treatment for Alzheimer's
disease? Front Mol Neurosci. 8:242015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Je IG, Kim HH, Park PH, Kwon TK, Seo SY,
Shin TY and Kim SH: SG-HQ2 inhibits mast cell-mediated allergic
inflammation through suppression of histamine release and
pro-inflammatory cytokines. Exp Biol Med (Maywood). 240:631–638.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nomicos EY: Myrrh: Medical marvel or myth
of the Magi? Holist Nurs Pract. 21:308–323. 2007. View Article : Google Scholar : PubMed/NCBI
|
